{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:51:33Z","timestamp":1774882293731,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T00:00:00Z","timestamp":1590451200000},"content-version":"vor","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007375","name":"Pr\u00f3-Reitoria de Pesquisa, Universidade Federal de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ejphar.2019.172404","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:04:11Z","timestamp":1558695851000},"page":"172404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["4-Methylbenzenecarbothioamide, a hydrogen sulfide donor, inhibits tumor necrosis factor-\u03b1 and CXCL1 production and exhibits activity in models of pain and inflammation"],"prefix":"10.1016","volume":"856","author":[{"given":"Ivo S.F.","family":"Melo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe F.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah O.A.M.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alysson Vin\u00edcius","family":"Braga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela \u00cdsis","family":"Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9ssica A.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo S.","family":"Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luzia V.","family":"Modolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio A.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata B.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ngelo","family":"de F\u00e1tima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio M.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renes R.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172404_bib1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bjp.0706186","article-title":"Hydrogen sulphide is a mediator of carrageenan-induced hindpaw oedema in the rat","volume":"145","author":"Bhatia","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib2","first-page":"172","article-title":"The N-benzyl thioamides","author":"Boudet","year":"1949","journal-title":"Bull. Soc. Chim. Fr."},{"key":"10.1016\/j.ejphar.2019.172404_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pain.2004.08.029","article-title":"Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells","volume":"112","author":"Brack","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2019.172404_bib4","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.1021\/jm901638j","article-title":"Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals","volume":"53","author":"Caliendo","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172404_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2008.05.048","article-title":"Dual role of hydrogen sulfide in mechanical inflammatory hypernociception","volume":"590","author":"Cunha","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2017.04.029","article-title":"Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: role of Kv7 potassium channels","volume":"121","author":"Di Cesari Manelli","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2019.172404_bib7","first-page":"1537","article-title":"Hydrogen sulfide releasing naproxen offers better anti-inflammatory and chondroprotective effect relative to naproxen in a rat model of zymosan induced arthritis","volume":"19","author":"Dief","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2019.172404_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2014.05.023","article-title":"Role of hydrogen sulfide in the formalin-induced orofacial pain in rats","volume":"738","author":"Donatti","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib9","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1476-5381.2010.00640.x","article-title":"Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat","volume":"159","author":"Ekundi-Valentim","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7555\/JBR.27.20120100","article-title":"Hydrogen sulfide protects against amyloid beta-peptide induced neuronal injury via attenuating inflammatory responses in a rat model","volume":"27","author":"Fan","year":"2013","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.ejphar.2019.172404_bib11","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjp.0707193","article-title":"Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis","volume":"150","author":"Fiorucci","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib12","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00011-015-0844-7","article-title":"Association of hydrogen sulfide with alterations of monocyte chemokine receptors, CCR2 and CX3CR1 in patients with coronary artery disease","volume":"64","author":"Gao","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.ejphar.2019.172404_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.bjp.0701882","article-title":"The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds","volume":"124","author":"Gray","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib14","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jpain.2013.06.008","article-title":"An overview of animal models of pain: disease models and outcome measures","volume":"14","author":"Gregory","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2019.172404_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/S1807-59322011000200023","article-title":"Effect of glibenclamide on antinociceptive effects of antidepressants of different classes","volume":"66","author":"Hajhashemi","year":"2011","journal-title":"Clinics"},{"key":"10.1016\/j.ejphar.2019.172404_bib16","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1039\/C6CS00212A","article-title":"A practical guide to working with H2S at the interface of chemistry and biology","volume":"45","author":"Hartle","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejphar.2019.172404_bib17","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/jo01127a025","article-title":"Conversion of nitriles to amides and acids by means of boron fluoride","volume":"20","author":"Hauser","year":"1955","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2019.172404_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ejp.720","article-title":"Rutin antinociception involves opioidergic mechanism and descending modulation of ventrolateral periaqueductal grey matter in rats","volume":"20","author":"Hernandez-Leon","year":"2016","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2019.172404_bib19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-4159.2006.04283.x","article-title":"Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia","volume":"100","author":"Hu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2019.172404_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-18144-8_1","article-title":"H2S synthesizing enzymes: biochemistry and molecular aspects","volume":"230","author":"Huang","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.pupt.2017.06.006","article-title":"Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice","volume":"45","author":"Kayar-Yasar","year":"2017","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2019.172404_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.niox.2014.11.014","article-title":"Inhaled hydrogen sulfide prevents neuropathic pain after peripheral nerve injury in mice","volume":"46","author":"Kida","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.ejphar.2019.172404_bib23","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2010-05-284513","article-title":"Myeloperoxidase attracts neutrophils by physical forces","volume":"117","author":"Klinke","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2019.172404_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.18433\/J3S597","article-title":"Pharmacokinetic of diclofenac in the presence and absence of glibenclamide in the rat","volume":"12","author":"Le\u00f3n-Reyes","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2019.172404_bib25","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1096\/fj.04-3583fje","article-title":"Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2019.172404_bib26","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.172404_bib27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.freeradbiomed.2009.04.014","article-title":"GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat","volume":"47","author":"Li","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2019.172404_bib28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jcmm.12016","article-title":"The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells","volume":"17","author":"Li","year":"2013","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2019.172404_bib29","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.juro.2016.05.029","article-title":"GYY4137, a slow-releasing hydrogen sulfide donor, ameliorates renal damage associated with chronic obstructive uropathy","volume":"196","author":"Lin","year":"2016","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2019.172404_bib30","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1021\/acs.jmedchem.5b01223","article-title":"Synthesis and pharmacological evaluation of novel adenine-hydrogen sulfide slow release hybrids designed as multitarget cardioprotective agents","volume":"59","author":"Lougiakis","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.172404_bib31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/ml400239a","article-title":"Arylthioamides as H2S donors: L-cysteine-activated releasing properties and vascular effects in vitro and in vivo","volume":"4","author":"Martelli","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2019.172404_bib32","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/bph.12806","article-title":"Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners","volume":"172","author":"Papapetropoulos","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib33","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/jcb.24495","article-title":"Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-\u03b1 activation","volume":"114","author":"Perna","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2019.172404_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjp.0705650","article-title":"Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression","volume":"142","author":"Posadas","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib35","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3892\/ijmm.2015.2176","article-title":"Hydrogen sulfide attenuates cytokine production through the modulation of chromatin remodeling","volume":"35","author":"Rios","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2019.172404_bib36","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.bjp.0706775","article-title":"Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw","volume":"148","author":"Rocha","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1476-5381.1996.tb15475.x","article-title":"Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation","volume":"118","author":"Salvemini","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","article-title":"Hydrogen sulphide and its therapeutic potential","volume":"6","author":"Szab\u00f3","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2019.172404_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bcp.2017.09.010","article-title":"A timeline of hydrogen sulfide (H2S) research: from environmental toxin to biological mediator","volume":"149","author":"Szab\u00f3","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib40","first-page":"121","article-title":"Pathophysiological concepts in multiple sclerosis and the therapeutic effects of hydrogen sulfide","volume":"7","author":"Talaei","year":"2016","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2019.172404_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tj\u00f8lsen","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2019.172404_bib42","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1096\/fj.07-8669com","article-title":"Hydrogen sulfide enhances ulcer healing in rats","volume":"21","author":"Wallace","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2019.172404_bib43","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1476-5381.2009.00611.x","article-title":"Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)","volume":"159","author":"Wallace","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib44","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1089\/ars.2017.7068","article-title":"Hydrogen sulfide-releasing therapeutics: translation to the clinic Antioxid","volume":"28","author":"Wallace","year":"2018","journal-title":"Redox Signal"},{"key":"10.1016\/j.ejphar.2019.172404_bib45","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?","volume":"16","author":"Wang","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2019.172404_bib46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/152308603768295249","article-title":"The gasotransmitter role of hydrogen sulfide","volume":"5","author":"Wang","year":"2003","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2019.172404_bib47","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1089\/ars.2009.2899","article-title":"The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages","volume":"12","author":"Whiteman","year":"2010","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2019.172404_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/ecp.10.134","article-title":"Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising","volume":"4","author":"Whiteman","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib49","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1017\/S1461145714000583","article-title":"Hydrogen sulfide inhibits opioid withdrawal-induced pain sensitization in rats by down-regulation of spinal calcitonin gene-related peptide expression in the spine","volume":"17","author":"Yang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2019.172404_bib50","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","article-title":"Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation","volume":"20","author":"Zanardo","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2019.172404_bib51","doi-asserted-by":"crossref","first-page":"e41147","DOI":"10.1371\/journal.pone.0041147","article-title":"Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172404_bib52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12974-017-0940-4","article-title":"Endogenous hydrogen sulphide attenuates NLRP3 inflammasome-mediated neuroinflammation by suppressing the P2X7 receptor after intracerebral haemorrhage in rats","volume":"14","author":"Zhao","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2019.172404_bib53","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1039\/C4CC00968A","article-title":"Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications","volume":"50","author":"Zhao","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejphar.2019.172404_bib54","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1535370217740859","article-title":"Preconditioning with hydrogen sulfide prevents bone cancer pain in rats through a proliferator-activated receptor gamma\/p38\/Jun N-terminal kinase pathway","volume":"243","author":"Zhuang","year":"2018","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejphar.2019.172404_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919303474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919303474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:27:50Z","timestamp":1757975270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919303474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":55,"alternative-id":["S0014299919303474"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172404","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Methylbenzenecarbothioamide, a hydrogen sulfide donor, inhibits tumor necrosis factor-\u03b1 and CXCL1 production and exhibits activity in models of pain and inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"172404"}}